Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
31.74
+0.18 (0.57%)
At close: Jan 9, 2026, 4:00 PM EST
31.74
0.00 (0.00%)
After-hours: Jan 9, 2026, 4:10 PM EST
Assembly Biosciences Stock Forecast
Stock Price Forecast
The 5 analysts that cover Assembly Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $43.4, which forecasts a 36.74% increase in the stock price over the next year. The lowest target is $38 and the highest is $50.
Price Target: $43.4 (+36.74%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Assembly Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 3 | 3 | 3 | 3 |
| Buy | 0 | 1 | 1 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +57.53% | Dec 22, 2025 |
| Mizuho | Mizuho | Buy Maintains $29 → $40 | Buy | Maintains | $29 → $40 | +26.02% | Nov 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +57.53% | Oct 14, 2025 |
| JMP Securities | JMP Securities | Buy Initiates $38 | Buy | Initiates | $38 | +19.72% | Sep 24, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $31 → $39 | Strong Buy | Maintains | $31 → $39 | +22.87% | Sep 8, 2025 |
Financial Forecast
Revenue This Year
38.03M
from 28.52M
Increased by 33.33%
Revenue Next Year
22.28M
from 38.03M
Decreased by -41.42%
EPS This Year
-3.63
from -6.69
EPS Next Year
-3.55
from -3.63
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 42.4M | 43.2M | ||||
| Avg | 38.0M | 22.3M | ||||
| Low | 29.4M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 48.8% | 13.7% | ||||
| Avg | 33.3% | -41.4% | ||||
| Low | 3.1% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.47 | -2.43 | ||||
| Avg | -3.63 | -3.55 | ||||
| Low | -3.79 | -5.53 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.